|
US3239539A
(en)
*
|
1960-12-02 |
1966-03-08 |
Exxon Research Engineering Co |
Gem dimethylol alicyclic esters
|
|
GB1026401A
(en)
|
1961-02-23 |
1966-04-20 |
Wellcome Found |
Isatin thiosemicarbazones,their preparation and pharmaceutical formulations containing them
|
|
US3250791A
(en)
*
|
1961-12-29 |
1966-05-10 |
Du Pont |
Tetracyanoethylene oxide and process for preparing same
|
|
GB1231783A
(en)
|
1967-05-16 |
1971-05-12 |
May & Baker Ltd |
Benzene derivatives
|
|
DE1767924A1
(de)
|
1968-07-02 |
1971-10-07 |
Bayer Ag |
1-Phenyl-4,4-dialkyl-thiosemicarbazide
|
|
JPS5695161A
(en)
*
|
1979-12-28 |
1981-08-01 |
Otsuka Pharmaceut Factory Inc |
2-admantanon derivative
|
|
US4463077A
(en)
*
|
1982-05-26 |
1984-07-31 |
Toray Industries, Inc. |
Electrophotographic photosensitive material comprises pyrazoline and hydrazone derivatives
|
|
US4537844A
(en)
|
1982-10-08 |
1985-08-27 |
Ricoh Co. Ltd. |
Electrophotographic element containing disazo compound
|
|
DE3237649A1
(de)
|
1982-10-11 |
1984-04-12 |
Hoechst Ag, 6230 Frankfurt |
3-aryl-7-chlor-10-hydroxy-3,4-dihydro-acridin-1,9-(2h, 10h)-dion-1-oxime und -1-hydrazonderivate, deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
|
|
EP0106284B1
(de)
*
|
1982-10-11 |
1987-06-16 |
Hoechst Aktiengesellschaft |
3-Aryl-7-chlor-3,4-dihydro-acridin-1,9-(2H,10H)-dion-1-oxime und -1-hydrazonderivate, deren Salze, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung
|
|
HU189765B
(en)
|
1983-10-25 |
1986-07-28 |
Richter Gedeon Vegyeszeti Gyar Rt,Hu |
Process for preparing n-substituted 1-(bis (hydroxy-metiol)-methyl)-isoquinoline-derivatives
|
|
US4619878A
(en)
|
1984-06-26 |
1986-10-28 |
Ricoh Co., Ltd. |
Tetrazonium salt compound, disazo compound, method for preparing the same, and photosensitive material containing said disazo compound for use in electrophotography
|
|
EP0183398B1
(en)
|
1984-11-30 |
1989-04-12 |
FISONS plc |
Angiotensin converting enzyme inhibitors and their production and use as pharmaceuticals
|
|
US4833153A
(en)
|
1985-11-08 |
1989-05-23 |
Glaxo Group Limited |
Indole derivatives
|
|
IL77496A
(en)
*
|
1986-01-01 |
1989-02-28 |
Univ Ramot |
Anti-viral preparations comprising isatine 3-thiosemicarbazones
|
|
JPH01502022A
(ja)
|
1986-04-07 |
1989-07-13 |
ジ・アップジョン・カンパニー |
駆虫薬第４級アルキルアシルヒドラゾン、使用方法および組成物
|
|
US5023334A
(en)
|
1986-10-03 |
1991-06-11 |
The Upjohn Company |
Anthelmintic pyridinyl acylhydrazones
|
|
ES2059527T3
(es)
|
1987-09-09 |
1994-11-16 |
Zeneca Ltd |
Fungicidas.
|
|
US5155110A
(en)
|
1987-10-27 |
1992-10-13 |
Warner-Lambert Company |
Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
|
|
US4958010A
(en)
|
1988-02-16 |
1990-09-18 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside lactam derivatives
|
|
ZA894508B
(en)
|
1988-06-16 |
1990-03-28 |
Rohm & Haas |
Pharmaceutical compounds
|
|
JP2521137B2
(ja)
|
1988-11-08 |
1996-07-31 |
富士写真フイルム株式会社 |
電子写真感光体
|
|
US5196291A
(en)
*
|
1989-05-24 |
1993-03-23 |
Fuji Photo Film Co., Ltd. |
Silver halide photographic material
|
|
EP0420005B1
(en)
|
1989-09-18 |
1996-07-10 |
Fuji Photo Film Co., Ltd. |
High contrast silver halide photographic material
|
|
YU201090A
(sh)
|
1989-10-25 |
1993-05-28 |
Egis Gyogyszergyar |
Novi triazolo derivati i postupak za njihovo pravljenje
|
|
US5008270A
(en)
|
1989-10-31 |
1991-04-16 |
Biocryst, Inc. |
2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
|
|
US4985434A
(en)
|
1989-10-31 |
1991-01-15 |
Biocryst, Inc. |
7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
|
|
US5008265A
(en)
|
1989-10-31 |
1991-04-16 |
Biocryst, Inc. |
2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
|
|
US4985433A
(en)
|
1989-10-31 |
1991-01-15 |
Biocryst, Inc. |
2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
|
|
JP3093767B2
(ja)
|
1989-11-27 |
2000-10-03 |
松下電工株式会社 |
洗浄装置
|
|
US5189039A
(en)
|
1989-11-29 |
1993-02-23 |
Biocryst, Inc. |
7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same
|
|
US5230983A
(en)
|
1990-04-13 |
1993-07-27 |
Fuji Photo Film Co., Ltd. |
Silver halide photographic material
|
|
LU87766A1
(fr)
|
1990-07-20 |
1992-03-11 |
Oreal |
Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre
|
|
NZ239846A
(en)
*
|
1990-09-27 |
1994-11-25 |
Merck & Co Inc |
Sulphonamide derivatives and pharmaceutical compositions thereof
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
JPH05333467A
(ja)
|
1991-05-02 |
1993-12-17 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
US5710158A
(en)
|
1991-05-10 |
1998-01-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
USRE37650E1
(en)
|
1991-05-10 |
2002-04-09 |
Aventis Pharmacetical Products, Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
CA2102780C
(en)
|
1991-05-10 |
2007-01-09 |
Alfred P. Spada |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
US5714493A
(en)
|
1991-05-10 |
1998-02-03 |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
US5344836A
(en)
|
1991-11-11 |
1994-09-06 |
Ono Pharmaceutical Co., Ltd. |
Fused benzeneoxyacetic acid derivatives
|
|
DE4138820A1
(de)
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
|
|
JP2787630B2
(ja)
|
1992-02-06 |
1998-08-20 |
富士写真フイルム株式会社 |
ハロゲン化銀感光材料
|
|
DE4207400A1
(de)
|
1992-03-09 |
1993-09-16 |
Bayer Ag |
Hydrazone
|
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
|
US5358946A
(en)
*
|
1992-05-29 |
1994-10-25 |
The Du Pont Merck Pharmaceutical Company |
Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis
|
|
JP2994182B2
(ja)
|
1992-07-23 |
1999-12-27 |
石原産業株式会社 |
アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
|
|
EP0600832A1
(de)
|
1992-11-27 |
1994-06-08 |
Ciba-Geigy Ag |
Diaminobenzoe- und Diaminophthalsäurederivate und ihre Verfahren als Proteinkinase-Inhibitoren
|
|
TW251302B
(enExample)
*
|
1992-12-28 |
1995-07-11 |
Kao Corp |
|
|
US5618829A
(en)
|
1993-01-28 |
1997-04-08 |
Mitsubishi Chemical Corporation |
Tyrosine kinase inhibitors and benzoylacrylamide derivatives
|
|
US5750088A
(en)
|
1993-03-30 |
1998-05-12 |
The Dupont Merck Pharmaceutical Company |
Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
|
|
JP3350739B2
(ja)
|
1993-06-10 |
2002-11-25 |
コニカ株式会社 |
黒白ハロゲン化銀写真感光材料の現像処理方法
|
|
US5543520A
(en)
|
1993-10-01 |
1996-08-06 |
Ciba-Geigy Corporation |
Pyrimidine derivatives
|
|
JPH08503971A
(ja)
|
1993-10-01 |
1996-04-30 |
チバ−ガイギー アクチェンゲゼルシャフト |
ピリミジンアミン誘導体及びその調製のための方法
|
|
US5656643A
(en)
|
1993-11-08 |
1997-08-12 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
PL315941A1
(en)
|
1994-02-23 |
1996-12-09 |
Pfizer |
4-heterocyclic substituted derivatives of quinazoline, methods of obtaining them and their application as anticarcinogenic agents
|
|
CN1176918C
(zh)
|
1994-04-06 |
2004-11-24 |
盐野义制药株式会社 |
具有农用杀菌活性的新型α-取代苯乙酸衍生物的中间体
|
|
EP0704215A3
(en)
*
|
1994-06-02 |
1998-04-01 |
Takeda Chemical Industries, Ltd. |
Inhibitor of vascular permeability enhancer
|
|
TW280906B
(enExample)
|
1994-12-01 |
1996-07-11 |
Ibm |
|
|
DE19501481A1
(de)
|
1995-01-19 |
1996-07-25 |
Bayer Ag |
2,8-Disubstituierte Chinazolinone
|
|
JPH08220666A
(ja)
|
1995-02-15 |
1996-08-30 |
Konica Corp |
黒白ハロゲン化銀写真感光材料及びその処理方法
|
|
EP0824525B1
(en)
|
1995-04-27 |
2001-06-13 |
AstraZeneca AB |
Quinazoline derivatives
|
|
US6265427B1
(en)
|
1995-06-07 |
2001-07-24 |
The Proctor & Gamble Company |
Pharmaceutical composition for the method of treating leukemia
|
|
DE69618587T2
(de)
|
1995-06-07 |
2002-08-29 |
Sugen, Inc. |
Chinazoline und pharmazeutische zusammensetzungen
|
|
US5763470A
(en)
|
1995-06-07 |
1998-06-09 |
Sugen Inc. |
Benzopyran compounds and methods for their use
|
|
US5633786A
(en)
|
1995-08-21 |
1997-05-27 |
Motorola |
Shield assembly and method of shielding suitable for use in a communication device
|
|
AR004010A1
(es)
|
1995-10-11 |
1998-09-30 |
Glaxo Group Ltd |
Compuestos heterociclicos
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DE19545878A1
(de)
|
1995-12-08 |
1997-06-12 |
Basf Ag |
Pyridylcarbamate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung
|
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
|
DE19619518A1
(de)
|
1996-05-15 |
1997-11-20 |
Haeussler & Sauter Kg |
Verfahren zur Anbringung eines Fadens an einem Aufgußbeutel
|
|
US6306574B1
(en)
|
1996-05-17 |
2001-10-23 |
Fuji Photo Film Co., Ltd. |
Photothermographic material
|
|
US20040171032A1
(en)
*
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
|
HRP970371A2
(en)
|
1996-07-13 |
1998-08-31 |
Kathryn Jane Smith |
Heterocyclic compounds
|
|
DE69716916T2
(de)
|
1996-07-13 |
2003-07-03 |
Glaxo Group Ltd., Greenford |
Kondensierte heterozyklische verbindungen als protein kinase inhibitoren
|
|
EA199900021A1
(ru)
|
1996-07-13 |
1999-08-26 |
Глаксо, Груп Лимитед |
Бициклические гетероароматические соединения в качестве ингибиторов протеинтирозинкиназы
|
|
AU720429B2
(en)
|
1996-08-23 |
2000-06-01 |
Novartis Ag |
Substituted pyrrolopyrimidines and processes for their preparation
|
|
ES2239779T3
(es)
|
1996-10-02 |
2005-10-01 |
Novartis Ag |
Derivados de pirimidina y procedimientos para la preparacion de los mismos.
|
|
CO4940418A1
(es)
|
1997-07-18 |
2000-07-24 |
Novartis Ag |
Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
|
|
ZA986729B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitors of tyrosine kinases
|
|
ZA986732B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitiors of tyrosine kinases
|
|
GB9716557D0
(en)
|
1997-08-06 |
1997-10-08 |
Glaxo Group Ltd |
Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
|
|
EP0902028A1
(en)
|
1997-09-11 |
1999-03-17 |
E.I. Du Pont De Nemours And Company |
Tetrazoline herbicides
|
|
US6184377B1
(en)
|
1997-12-15 |
2001-02-06 |
Sepracor Inc. |
Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
|
|
AU1507199A
(en)
|
1997-12-15 |
1999-07-05 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel pyrimidine-5-carboxamide derivatives
|
|
DE69918950T2
(de)
|
1998-02-06 |
2005-07-28 |
De Montfort University |
Durch hydroxylierung aktivierte medikamentvorstufen
|
|
US20020042423A1
(en)
|
1998-04-29 |
2002-04-11 |
John R. Richert |
Methods for identifying compounds that bind to hla molecules and use of such compounds as hla-agonists or antagonists
|
|
US20010051628A1
(en)
|
1998-05-04 |
2001-12-13 |
H.-J. Su Huang |
Methods to modulate the resistance of cells to apoptosis mediated by mutant epidermal growth factor receptors
|
|
US6289352B1
(en)
|
1998-05-29 |
2001-09-11 |
Crystal Decisions, Inc. |
Apparatus and method for compound on-line analytical processing in databases
|
|
JPH11345811A
(ja)
|
1998-06-01 |
1999-12-14 |
Seiko Instruments Inc |
半導体装置の製造方法
|
|
US6596770B2
(en)
|
2000-05-05 |
2003-07-22 |
Medinox, Inc. |
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
|
|
US20030181495A1
(en)
|
1998-06-23 |
2003-09-25 |
Medinox, Inc. |
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
|
|
EP1117397A1
(en)
|
1998-08-31 |
2001-07-25 |
Sugen, Inc. |
Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
|
|
JP2000143636A
(ja)
|
1998-09-02 |
2000-05-26 |
Sumitomo Pharmaceut Co Ltd |
アミノ誘導体
|
|
US20020010550A1
(en)
|
1998-09-14 |
2002-01-24 |
George M. Grass |
Pharmacokinetic-based drug design tool and method
|
|
US6420560B1
(en)
*
|
1999-06-07 |
2002-07-16 |
Theravance, Inc. |
H1—histamine receptor antagonists
|
|
AU5469400A
(en)
*
|
1999-06-11 |
2001-01-02 |
Merck & Co., Inc. |
Cyclopentyl modulators of chemokine receptor activity
|
|
KR20020027649A
(ko)
|
1999-09-15 |
2002-04-13 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
카이나제 억제제로서의 프테리딘온
|
|
US7264932B2
(en)
|
1999-09-24 |
2007-09-04 |
Applera Corporation |
Nuclease inhibitor cocktail
|
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JP2001172217A
(ja)
|
1999-12-21 |
2001-06-26 |
Shionogi & Co Ltd |
殺ダニ活性および殺菌活性を有するエチレン誘導体
|
|
GB2357971A
(en)
|
1999-12-23 |
2001-07-11 |
Novartis Ag |
Protection of plants against microorganism attack
|
|
ITMI992711A1
(it)
|
1999-12-27 |
2001-06-27 |
Novartis Ag |
Composti organici
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
IL145757A
(en)
|
2000-02-05 |
2007-12-03 |
Vertex Pharma |
History of pyrazole and pharmaceutical preparations containing them
|
|
US6420382B2
(en)
|
2000-02-25 |
2002-07-16 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6313138B1
(en)
|
2000-02-25 |
2001-11-06 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
EP1259490A2
(en)
|
2000-03-01 |
2002-11-27 |
Sloan Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
|
GB0007657D0
(en)
|
2000-03-29 |
2000-05-17 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB2372562A
(en)
|
2000-04-26 |
2002-08-28 |
Ribotargets Ltd |
In silico screening
|
|
DE60141871D1
(de)
|
2000-05-05 |
2010-06-02 |
Wallac Oy |
Oligonukleotidmarkierungsstoffe und ihre Verwendung
|
|
DE10023492A1
(de)
|
2000-05-09 |
2001-11-22 |
Schering Ag |
Aza- und Polyazanthranylamide und deren Verwendung als Arzneimittel
|
|
US6489094B2
(en)
|
2000-05-31 |
2002-12-03 |
Pfizer Inc. |
Method and device for drug-drug interaction testing sample preparation
|
|
US7211192B2
(en)
|
2000-06-02 |
2007-05-01 |
The Regents Of The University Of California |
Hybrid organic-inorganic adsorbents
|
|
US7022484B2
(en)
|
2000-06-08 |
2006-04-04 |
Board Of Regents, The University Of Texas System |
Methods for treating neuropathological states and neurogenic inflammatory states and methods for identifying compounds useful therein
|
|
US20020028826A1
(en)
|
2000-06-15 |
2002-03-07 |
Robl Jeffrey A. |
HMG-CoA reductase inhibitors and method
|
|
US20020013334A1
(en)
|
2000-06-15 |
2002-01-31 |
Robl Jeffrey A. |
HMG-CoA reductase inhibitors and method
|
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
EP1294349A2
(en)
|
2000-06-26 |
2003-03-26 |
The Regents Of The University Of Michigan |
Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin
|
|
US7175844B2
(en)
|
2000-07-18 |
2007-02-13 |
Joslin Diabetes Center, Inc. |
Methods of modulating fibrosis
|
|
US7067046B2
(en)
|
2000-08-04 |
2006-06-27 |
Essen Instruments, Inc. |
System for rapid chemical activation in high-throughput electrophysiological measurements
|
|
US6647342B2
(en)
|
2000-08-07 |
2003-11-11 |
Novodynamics, Inc. |
Knowledge-based process for the development of materials
|
|
GB0022438D0
(en)
|
2000-09-13 |
2000-11-01 |
Novartis Ag |
Organic Compounds
|
|
CA2424689A1
(en)
|
2000-10-17 |
2002-04-25 |
Merck & Co., Inc. |
Orally active salts with tyrosine kinase activity
|
|
US7759323B2
(en)
|
2001-05-22 |
2010-07-20 |
Eisai R & D Management Co., Ltd. |
Highly purified antiendotoxin compound
|
|
JP2002361158A
(ja)
|
2001-06-07 |
2002-12-17 |
Aica Kogyo Co Ltd |
塗布装置
|
|
US6352168B1
(en)
|
2001-06-21 |
2002-03-05 |
Jung-Chuang Lin |
Rotation cup
|
|
US20040235798A1
(en)
|
2001-07-05 |
2004-11-25 |
Murthi Krishna K |
Compositions and methods for inhibiting prenyltransferases
|
|
EP1406889A2
(en)
|
2001-07-09 |
2004-04-14 |
Pharmacia Italia S.p.A. |
Interaction inhibitors of tcf-4 with beta-catenin
|
|
US7071190B2
(en)
*
|
2002-02-15 |
2006-07-04 |
Rigel Pharmaceuticals, Inc. |
Inhibitors to tubulin polymerization
|
|
FR2840303B1
(fr)
|
2002-05-31 |
2005-07-15 |
Rhodia Chimie Sa |
Procede d'arylation ou de vinylation ou d'alcylynation d'un compose nucleophile
|
|
KR20040105853A
(ko)
*
|
2002-04-08 |
2004-12-16 |
토렌트 파마슈티칼스 리미티드 |
티아졸리딘-4-카르보니트릴 및 유사체와디펩티딜-펩티다아제 억제제로서의 용도
|
|
JP4398866B2
(ja)
*
|
2002-10-18 |
2010-01-13 |
ビーエーエスエフ ソシエタス・ヨーロピア |
１−フェニルピロリジン−２−オン−３−カルボキサミド
|
|
US20060252798A1
(en)
|
2003-02-05 |
2006-11-09 |
Richardson Desi R |
Metal ion chelators and therapeutic use thereof
|
|
EP1594894A2
(en)
|
2003-02-18 |
2005-11-16 |
Whitehead Institute For Biomedical Research |
Mtor kinase-associated proteins
|
|
WO2004085382A1
(ja)
|
2003-03-27 |
2004-10-07 |
Kirin Beer Kabushiki Kaisha |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
|
US20040193538A1
(en)
|
2003-03-31 |
2004-09-30 |
Raines Walter L. |
Receipt processing system and method
|
|
US7427683B2
(en)
*
|
2003-04-25 |
2008-09-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
c-fms kinase inhibitors
|
|
US20050010017A1
(en)
*
|
2003-07-11 |
2005-01-13 |
Blakely Dale Milton |
Addition of UV inhibitors to pet process for maximum yield
|
|
US20050249697A1
(en)
|
2003-09-24 |
2005-11-10 |
Uhrich Kathryn E |
Compositions and methods for the inhibition of bone growth and resorption
|
|
WO2005070133A2
(en)
*
|
2004-01-20 |
2005-08-04 |
Merck & Co., Inc. |
2,6-disubstituted piperidines as modulators of chemokine receptor activity
|
|
KR20120090077A
(ko)
|
2004-01-30 |
2012-08-16 |
얀센 알 앤드 디 아일랜드 |
Ｈｃｖ ｎｓ?３ 세린 프로테아제 저해제
|
|
ZA200607582B
(en)
|
2004-03-05 |
2009-02-25 |
Univ California |
Anti-parasitic compounds and methods of their use
|
|
EP1799679B1
(de)
*
|
2004-10-13 |
2008-01-23 |
Merck Patent GmbH |
Als kinaseinhibitoren geeignete derivate des n,n'-diphenylharnstoffs
|
|
FR2879194B1
(fr)
*
|
2004-12-14 |
2007-01-19 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques modulateurs des recepteurs de type ppar, leur procede de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
JP2006181940A
(ja)
|
2004-12-28 |
2006-07-13 |
Mitsubishi Paper Mills Ltd |
インクジェット用記録材料
|
|
CN1891701A
(zh)
|
2005-07-07 |
2007-01-10 |
桑迪亚医药技术（上海）有限责任公司 |
杂芳环缩氨基硫脲类化合物及其衍生物和它们在制备抗肿瘤药物中的应用
|
|
CN100497309C
(zh)
|
2005-08-04 |
2009-06-10 |
卡南吉医药科技（上海）有限公司 |
杂芳环缩氨基硫脲类抗肿瘤药物的合成方法
|
|
US20100016298A1
(en)
|
2005-08-29 |
2010-01-21 |
Housey Gerad M |
Theramutein modulators
|
|
WO2007106503A2
(en)
|
2006-03-13 |
2007-09-20 |
Osi Pharmaceuticals, Inc. |
Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
|
|
JP2008008853A
(ja)
|
2006-06-30 |
2008-01-17 |
Univ Of Electro-Communications |
地点間距離変動検出装置及び方法
|
|
JP2008088107A
(ja)
|
2006-10-02 |
2008-04-17 |
Fujiyakuhin Co Ltd |
新規ピリダジン誘導体
|
|
CA2673683C
(en)
|
2007-01-11 |
2014-07-29 |
Critical Outcome Technologies, Inc. |
Compounds and method for treatment of cancer
|
|
CA2710039C
(en)
|
2007-12-26 |
2018-07-03 |
Critical Outcome Technologies, Inc. |
Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer
|
|
CA2730890C
(en)
|
2008-07-17 |
2018-05-15 |
Critical Outcome Technologies Inc. |
Thiosemicarbazone inhibitor compounds and cancer treatment methods
|